ASRT Assertio Holdings Inc

Assertio Therapeutics, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), today announced that it will release fourth quarter and full year 2019 financial results on Monday, March 9, 2020, after the close of markets. Following the announcement, the Company will host a conference call beginning at 3:30 p.m. central standard time to discuss its results.

Participants can access the live webcast from the Investor Relations section of Assertio's website at http://investor.assertiotx.com. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software.

Audio Conference Call:

U.S. Dial-in Number: 1-877-550-3745

International Dial-in Number: 1-281-973-6277

Conference ID: 2099224

An archived webcast replay will be available on the Company's website accessed by visiting http://investor.assertiotx.com.

About Assertio Therapeutics, Inc. Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets two FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies.

To learn more about Assertio, visit www.assertiotx.com.

Investor and Media Contact: Dan Peisert Senior Vice President and Chief Financial Officerdpeisert@assertiotx.comSource: Assertio Therapeutics, Inc.